Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Identifieur interne : 000238 ( Main/Exploration ); précédent : 000237; suivant : 000239Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Auteurs : Haggar H. Ampadu [Ghana] ; Jarno Hoekman [Pays-Bas] ; Marieke L. De Bruin [Pays-Bas] ; Shanthi N. Pal [Suisse] ; Sten Olsson [Suède] ; Daniele Sartori [Suède] ; Hubert G M. Leufkens [Pays-Bas] ; Alexander N O. Dodoo [Ghana]Source :
- Drug safety [ 1179-1942 ] ; 2016.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Afrique, Agents antiVIH (effets indésirables), Bases de données pharmaceutiques, Femelle, Humains, Inhibiteurs de l'enzyme de conversion de l'angiotensine (effets indésirables), Inhibiteurs de la transcriptase inverse (effets indésirables), Jeune adulte, Mâle, Pharmacovigilance, Systèmes de signalement des effets indésirables des médicaments.
- MESH :
- effets indésirables : Agents antiVIH, Inhibiteurs de l'enzyme de conversion de l'angiotensine, Inhibiteurs de la transcriptase inverse.
- Adolescent, Adulte, Adulte d'âge moyen, Afrique, Bases de données pharmaceutiques, Femelle, Humains, Jeune adulte, Mâle, Pharmacovigilance, Systèmes de signalement des effets indésirables des médicaments.
English descriptors
- KwdEn :
- Adolescent, Adult, Adverse Drug Reaction Reporting Systems, Africa, Angiotensin-Converting Enzyme Inhibitors (adverse effects), Anti-HIV Agents (adverse effects), Databases, Pharmaceutical, Female, Humans, Male, Middle Aged, Pharmacovigilance, Reverse Transcriptase Inhibitors (adverse effects), Young Adult.
- MESH :
Abstract
Following the start of the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM) by 10 member countries in 1968, it took another 24 years for the first two African countries to join in 1992, by which time the number of member countries in the PIDM had grown to 33. Whilst pharmacovigilance (PV), including the submission of individual case safety reports (ICSR) to VigiBase(®), the WHO global ICSR database, is growing in Africa, no data have been published on the growth of ICSR reporting from Africa and how the features of ICSRs from Africa compare with the rest of the world (RoW).
DOI: 10.1007/s40264-015-0387-4
PubMed: 26754924
Affiliations:
- Ghana, Pays-Bas, Suisse, Suède
- Région du Grand Accra, Utrecht (province)
- Accra, Utrecht
- Université d'Utrecht, Université du Ghana
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000892
- to stream PubMed, to step Curation: 000891
- to stream PubMed, to step Checkpoint: 000891
- to stream Ncbi, to step Merge: 000928
- to stream Ncbi, to step Curation: 000928
- to stream Ncbi, to step Checkpoint: 000928
- to stream Main, to step Merge: 000238
- to stream Main, to step Curation: 000238
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.</title><author><name sortKey="Ampadu, Haggar H" sort="Ampadu, Haggar H" uniqKey="Ampadu H" first="Haggar H" last="Ampadu">Haggar H. Ampadu</name><affiliation wicri:level="4"><nlm:affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra, Ghana. haggar.ampadu@who-pvafrica.org.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Hoekman, Jarno" sort="Hoekman, Jarno" uniqKey="Hoekman J" first="Jarno" last="Hoekman">Jarno Hoekman</name><affiliation wicri:level="4"><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName><orgName type="university">Université d'Utrecht</orgName></affiliation></author><author><name sortKey="De Bruin, Marieke L" sort="De Bruin, Marieke L" uniqKey="De Bruin M" first="Marieke L" last="De Bruin">Marieke L. De Bruin</name><affiliation wicri:level="4"><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName><orgName type="university">Université d'Utrecht</orgName></affiliation></author><author><name sortKey="Pal, Shanthi N" sort="Pal, Shanthi N" uniqKey="Pal S" first="Shanthi N" last="Pal">Shanthi N. Pal</name><affiliation wicri:level="1"><nlm:affiliation>Safety and Vigilance, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Safety and Vigilance, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Olsson, Sten" sort="Olsson, Sten" uniqKey="Olsson S" first="Sten" last="Olsson">Sten Olsson</name><affiliation wicri:level="1"><nlm:affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Uppsala Monitoring Centre, Uppsala</wicri:regionArea><wicri:noRegion>Uppsala</wicri:noRegion></affiliation></author><author><name sortKey="Sartori, Daniele" sort="Sartori, Daniele" uniqKey="Sartori D" first="Daniele" last="Sartori">Daniele Sartori</name><affiliation wicri:level="1"><nlm:affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Uppsala Monitoring Centre, Uppsala</wicri:regionArea><wicri:noRegion>Uppsala</wicri:noRegion></affiliation></author><author><name sortKey="Leufkens, Hubert G M" sort="Leufkens, Hubert G M" uniqKey="Leufkens H" first="Hubert G M" last="Leufkens">Hubert G M. Leufkens</name><affiliation wicri:level="4"><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName><orgName type="university">Université d'Utrecht</orgName></affiliation></author><author><name sortKey="Dodoo, Alexander N O" sort="Dodoo, Alexander N O" uniqKey="Dodoo A" first="Alexander N O" last="Dodoo">Alexander N O. Dodoo</name><affiliation wicri:level="4"><nlm:affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26754924</idno><idno type="pmid">26754924</idno><idno type="doi">10.1007/s40264-015-0387-4</idno><idno type="wicri:Area/PubMed/Corpus">000892</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000892</idno><idno type="wicri:Area/PubMed/Curation">000891</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000891</idno><idno type="wicri:Area/PubMed/Checkpoint">000891</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000891</idno><idno type="wicri:Area/Ncbi/Merge">000928</idno><idno type="wicri:Area/Ncbi/Curation">000928</idno><idno type="wicri:Area/Ncbi/Checkpoint">000928</idno><idno type="wicri:Area/Main/Merge">000238</idno><idno type="wicri:Area/Main/Curation">000238</idno><idno type="wicri:Area/Main/Exploration">000238</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.</title><author><name sortKey="Ampadu, Haggar H" sort="Ampadu, Haggar H" uniqKey="Ampadu H" first="Haggar H" last="Ampadu">Haggar H. Ampadu</name><affiliation wicri:level="4"><nlm:affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra, Ghana. haggar.ampadu@who-pvafrica.org.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author><author><name sortKey="Hoekman, Jarno" sort="Hoekman, Jarno" uniqKey="Hoekman J" first="Jarno" last="Hoekman">Jarno Hoekman</name><affiliation wicri:level="4"><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName><orgName type="university">Université d'Utrecht</orgName></affiliation></author><author><name sortKey="De Bruin, Marieke L" sort="De Bruin, Marieke L" uniqKey="De Bruin M" first="Marieke L" last="De Bruin">Marieke L. De Bruin</name><affiliation wicri:level="4"><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName><orgName type="university">Université d'Utrecht</orgName></affiliation></author><author><name sortKey="Pal, Shanthi N" sort="Pal, Shanthi N" uniqKey="Pal S" first="Shanthi N" last="Pal">Shanthi N. Pal</name><affiliation wicri:level="1"><nlm:affiliation>Safety and Vigilance, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Safety and Vigilance, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Olsson, Sten" sort="Olsson, Sten" uniqKey="Olsson S" first="Sten" last="Olsson">Sten Olsson</name><affiliation wicri:level="1"><nlm:affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Uppsala Monitoring Centre, Uppsala</wicri:regionArea><wicri:noRegion>Uppsala</wicri:noRegion></affiliation></author><author><name sortKey="Sartori, Daniele" sort="Sartori, Daniele" uniqKey="Sartori D" first="Daniele" last="Sartori">Daniele Sartori</name><affiliation wicri:level="1"><nlm:affiliation>Uppsala Monitoring Centre, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Uppsala Monitoring Centre, Uppsala</wicri:regionArea><wicri:noRegion>Uppsala</wicri:noRegion></affiliation></author><author><name sortKey="Leufkens, Hubert G M" sort="Leufkens, Hubert G M" uniqKey="Leufkens H" first="Hubert G M" last="Leufkens">Hubert G M. Leufkens</name><affiliation wicri:level="4"><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName><orgName type="university">Université d'Utrecht</orgName></affiliation></author><author><name sortKey="Dodoo, Alexander N O" sort="Dodoo, Alexander N O" uniqKey="Dodoo A" first="Alexander N O" last="Dodoo">Alexander N O. Dodoo</name><affiliation wicri:level="4"><nlm:affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana, P.O Box GP 4236, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName><orgName type="university">Université du Ghana</orgName></affiliation></author></analytic><series><title level="j">Drug safety</title><idno type="eISSN">1179-1942</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Adverse Drug Reaction Reporting Systems</term><term>Africa</term><term>Angiotensin-Converting Enzyme Inhibitors (adverse effects)</term><term>Anti-HIV Agents (adverse effects)</term><term>Databases, Pharmaceutical</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pharmacovigilance</term><term>Reverse Transcriptase Inhibitors (adverse effects)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Afrique</term><term>Agents antiVIH (effets indésirables)</term><term>Bases de données pharmaceutiques</term><term>Femelle</term><term>Humains</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (effets indésirables)</term><term>Inhibiteurs de la transcriptase inverse (effets indésirables)</term><term>Jeune adulte</term><term>Mâle</term><term>Pharmacovigilance</term><term>Systèmes de signalement des effets indésirables des médicaments</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Anti-HIV Agents</term><term>Reverse Transcriptase Inhibitors</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Agents antiVIH</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term><term>Inhibiteurs de la transcriptase inverse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Adverse Drug Reaction Reporting Systems</term><term>Africa</term><term>Databases, Pharmaceutical</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pharmacovigilance</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Afrique</term><term>Bases de données pharmaceutiques</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pharmacovigilance</term><term>Systèmes de signalement des effets indésirables des médicaments</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Following the start of the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM) by 10 member countries in 1968, it took another 24 years for the first two African countries to join in 1992, by which time the number of member countries in the PIDM had grown to 33. Whilst pharmacovigilance (PV), including the submission of individual case safety reports (ICSR) to VigiBase(®), the WHO global ICSR database, is growing in Africa, no data have been published on the growth of ICSR reporting from Africa and how the features of ICSRs from Africa compare with the rest of the world (RoW).</div></front></TEI><affiliations><list><country><li>Ghana</li><li>Pays-Bas</li><li>Suisse</li><li>Suède</li></country><region><li>Région du Grand Accra</li><li>Utrecht (province)</li></region><settlement><li>Accra</li><li>Utrecht</li></settlement><orgName><li>Université d'Utrecht</li><li>Université du Ghana</li></orgName></list><tree><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Ampadu, Haggar H" sort="Ampadu, Haggar H" uniqKey="Ampadu H" first="Haggar H" last="Ampadu">Haggar H. Ampadu</name></region><name sortKey="Dodoo, Alexander N O" sort="Dodoo, Alexander N O" uniqKey="Dodoo A" first="Alexander N O" last="Dodoo">Alexander N O. Dodoo</name></country><country name="Pays-Bas"><region name="Utrecht (province)"><name sortKey="Hoekman, Jarno" sort="Hoekman, Jarno" uniqKey="Hoekman J" first="Jarno" last="Hoekman">Jarno Hoekman</name></region><name sortKey="De Bruin, Marieke L" sort="De Bruin, Marieke L" uniqKey="De Bruin M" first="Marieke L" last="De Bruin">Marieke L. De Bruin</name><name sortKey="Leufkens, Hubert G M" sort="Leufkens, Hubert G M" uniqKey="Leufkens H" first="Hubert G M" last="Leufkens">Hubert G M. Leufkens</name></country><country name="Suisse"><noRegion><name sortKey="Pal, Shanthi N" sort="Pal, Shanthi N" uniqKey="Pal S" first="Shanthi N" last="Pal">Shanthi N. Pal</name></noRegion></country><country name="Suède"><noRegion><name sortKey="Olsson, Sten" sort="Olsson, Sten" uniqKey="Olsson S" first="Sten" last="Olsson">Sten Olsson</name></noRegion><name sortKey="Sartori, Daniele" sort="Sartori, Daniele" uniqKey="Sartori D" first="Daniele" last="Sartori">Daniele Sartori</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000238 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000238 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26754924
|texte= Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26754924" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |